Results 81 to 90 of about 152,173 (217)
Breaking barriers in peritoneal fibrosis: extracellular vesicles as promising diagnostic and therapeutic strategy. [PDF]
Zhong L, Zhang B, Li Y, Su B, Liao R.
europepmc +1 more source
ABSTRACT Background Mesothelioma is a rare tumor that arises from the serosal cells lining the serous cavities, most commonly the pleura followed by the peritoneum. Presenting symptoms include pleuritic pain and bloody effusions that recur. Although cytologic analysis cannot determine the mesothelial subtype or in situ from invasive disease, the ...
Suzanne M. Selvaggi
wiley +1 more source
Feline infectious peritonitis: a coronavirus disease of cats [PDF]
Horzinek, M.C., Osterhaus, A.D.M.E.
openaire +3 more sources
Incidental Detection of Miliary Tuberculosis During Laparoscopic Cholecystectomy: A Case Report. [PDF]
Khan MA, Rahman S, Usman N.
europepmc +1 more source
ABSTRACT Clear cell sarcoma of soft tissue (CCSST) with malignant effusion is a rare yet clinically aggressive appearance, which may pose a diagnostic pitfall with its overlapping cytomorphologic features with metastatic melanoma and carcinoma.
William H. Wu +2 more
wiley +1 more source
Infertility Caused by Pelvic Tuberculosis: A Forgotten and Rare Diagnosis. [PDF]
Hashemi M, Dehghan M.
europepmc +1 more source
Biomarkers of lung congestion and injury in acute heart failure
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi +9 more
wiley +1 more source
MEF2A nuclear translocation mediated by ROCK phosphorylation promotes EZH2 expression and peritoneal fibrosis. [PDF]
Chen D, Sun Z, Xu Y, Wang Q.
europepmc +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source

